MIRA INFORM REPORT

 

 

Report Date :

29th December, 2006

 

IDENTIFICATION DETAILS

 

Name :

EGYPTIAN PHARMACISTS COMPANY SAE (EPC)

 

 

Registered Office :

5C, Square No. 1185, Sheraton Heliopolis Area, Cairo, Egypt

 

 

Country :

Egypt

 

 

Date of Incorporation :

1996

 

 

Com. Reg. No.:

296285, Cairo

 

 

Legal Form :

Societe Anonyme Egyptienne – SAE (Egyptian Joint Stock Company)

 

 

Line of Business :

Manufacturing, bulk packaging, distribution, import, export, and marketing of food supplements and drugs.

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

US$ 250,000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 


 

SUMMARY

 

 

Company Name

EGYPTIAN PHARMACISTS COMPANY SAE (EPC)

Country of Origin

Egypt

Legal Form

Egyptian Joint Stock Company

Registration Date

1996

Commercial Registration Number

296285, Cairo

Issued Capital

£E 4,500,000

Paid up Capital

£E 4,500,000

Total Workforce

50

Line of Business

Manufacturing, bulk packaging, distribution, import, export, and marketing of food supplements and drugs.

Financial Condition

Fair

Payments

Nothing detrimental uncovered

Operating Trend

Steady

 

 

 


COMPANY NAME

 

EGYPTIAN PHARMACISTS COMPANY SAE (EPC)

 

 

ADDRESS

 

Registered & Physical Address

 

Location            : 5C, Square No. 1185, Sheraton Heliopolis Area

Town                 : Cairo

Country             : Egypt

Telephone         : (20-2) 2683567 / 2683569

Facsimile          : (20-2) 2682172

 

 

Premises

 

Subject operates from a medium sized suite of offices that are rented and located in the Suburban Business Area of Cairo.

 

 

KEY PRINCIPALS

 

·       Dr. Ezzat Ali Ismail                                                               Chairman

 

·       Dr. Moustafa Abd El Salam                                                    Managing Director

 

·       Dr. Moustafa Roushdy                                                           Director

 

·       Dr. Ahmed El Adawy                                                             Director

 

·       Dr. Diaa Youssef Ghobrial                                                      Director

 

·       Dr. Sherif Wally                                                                     Director

 

·       Dr. Moustafa Gamgoum                                                         Director

 

·       Dr. Karam Kordy Abd El Fattah                                              Director

 

·       Dr. Mohamed Essam Omar                                                    Director

 

·       Dr. Mohamed Adel Abu El Ela                                                Director

 

·       Khaled Mohamed El Sheshaty                                               Finance Manager

 

·       Mohamed Abd El Khalek                                                       Accounts Manager

 

 

LEGAL FORM & OWNERS

 

Date of Establishment  : 1996

 

Legal Form                  : Societe Anonyme Egyptienne – SAE (Egyptian Joint Stock Company)

 

Commercial Reg. No.  : 296285, Cairo

 

Issued Capital              : £E 4,500,000

 

Paid up Capital            : £E 4,500,000

 

 

Name of Shareholder (s)

 

·       Dr. Ezzat Ali Ismail

 

·       Dr. Moustafa Abd El Salam

 

·       Dr. Moustafa Roushdy

 

·       Dr. Ahmed El Adawy

 

·       Dr. Diaa Youssef Ghobrial

 

·       Dr. Sherif Wally

 

·       Dr. Moustafa Gamgoum

 

·       Dr. Karam Kordy Abd El Fattah

 

·       Dr. Mohamed Essam Omar

 

·       Dr. Mohamed Adel Abu El Ela

 

·       350 Egyptian pharmacists

 

Note to the Legal Form  

The Egyptian Company Law provides that the capital of a Societe Anonyme Egyptienne - SAE – should not be less than £E 500,000 if shares are offered to the public and £E 250,000 if not. If shares are offered to the public they are freely transferable, if not, transfer may be restricted. Liability of shareholders is limited.

 

 

LINE OF BUSINESS

 

Operations : Engaged in the manufacturing, bulk packaging, distribution, import, export, and marketing of food supplements and drugs.

 

Import Countries : Canada, United States of America, Italy, Denmark, United Kingdom, Switzerland, and China.

 

Operating Trend : Steady

 

Subject has a workforce of 50 employees.

 

 

FINANCIAL HIGHLIGHTS

 

Companies registered in Egypt are not legally required to make their accounts public and no financial information was released by the company or submitted by outside sources.

 

 

BANKERS

 

·       Banque du Caire Barclays Internationale SAE

12, Midan El Sheikh Youssef Street

Garden City

PO Box: 110, Maglis El Shaab

Cairo

Tel   : (20-2) 3542195 / 3549415 / 3549422

Fax  : (20-2) 3552746

 

·       Banque Misr

151 Mohamed Farid Street

Cairo

Tel   : (20-2) 3912711 / 3912106

Fax : (20-2) 3919779

 

·       National Societe General Bank

5 Champollion Street

Cairo

Tel   : (20-2) 7707777

Fax  : (20-2) 7707799

 

 

PAYMENT HISTORY

 

No complaints regarding subject’s payments have been reported.

 

 

GENERAL COMMENTS

 

Opinion on the credit figure of US$ 100,000

 

During the course of this investigation nothing detrimental was uncovered regarding subject’s operating history or the manner in which payments are fulfilled. As such the company is considered to be a fair trade risk and the above credit figure is within subject’s financial means.

 

Maximum suggested credit figure: US$ 250,000


 

RATING EXPLANATIONS

 

 

RATING

STATUS

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average/normal.

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions